Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

RANI THERAPEUTICS HOLDINGS, INC.

(RANI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Rani Therapeutics : Cantor Fitzgerald Starts Rani Therapeutics Holdings at Overweight with $23 Price Target

08/24/2021 | 08:47am EST


ę MT Newswires 2021
All news about RANI THERAPEUTICS HOLDINGS, INC.
01/07Rani Therapeutics Appoints Lisa Rometty to Board of Directors
AQ
01/05RANI THERAPEUTICS HOLDINGS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
01/05Rani Therapeutics Holdings, Inc. Announces Appointment of Lisa Rometty as Director
CI
2021RANI THERAPEUTICS HOLDINGS, INC.(NAS : RANI) added to NASDAQ Biotechnology Index
CI
2021RANI THERAPEUTICS HOLDINGS, INC.(NAS : RANI) added to S&P Global BMI Index
CI
2021RANI THERAPEUTICS : Reports Third Quarter 2021 Financial Results, Provides Corporate Updat..
PU
2021RANI THERAPEUTICS HOLDINGS, INC. Management's Discussion and Analysis of Financial Con..
AQ
2021Rani Therapeutics Reports Third Quarter 2021 Financial Results, Provides Corporate Upda..
GL
2021Rani Therapeutics Reports Third Quarter 2021 Financial Results, Provides Corporate Upda..
GL
2021RANI THERAPEUTICS HOLDINGS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
More news
Analyst Recommendations on RANI THERAPEUTICS HOLDINGS, INC.
More recommendations
Financials (USD)
Sales 2021 2,92 M - -
Net income 2021 -52,4 M - -
Net Debt 2021 - - -
P/E ratio 2021 -16,6x
Yield 2021 -
Capitalization 362 M 362 M -
Capi. / Sales 2021 124x
Capi. / Sales 2022 315x
Nbr of Employees 91
Free-Float -
Chart RANI THERAPEUTICS HOLDINGS, INC.
Duration : Period :
Rani Therapeutics Holdings, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends RANI THERAPEUTICS HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 18,37 $
Average target price 28,40 $
Spread / Average Target 54,6%
EPS Revisions
Managers and Directors
Talat Imran Chief Executive Officer & Director
Svai S. Sanford Chief Financial Officer
Mir A. Imran Executive Chairman
Mir Hashim Chief Scientific Officer
Dennis Arthur Ausiello Independent Director
Sector and Competitors
1st jan.Capi. (M$)
RANI THERAPEUTICS HOLDINGS, INC.12.35%362
MODERNA, INC.-38.07%63 777
LONZA GROUP AG-19.59%49 711
IQVIA HOLDINGS INC.-13.62%46 556
SEAGEN INC.-16.20%23 689
ICON PUBLIC LIMITED COMPANY-17.32%20 842